0001209191-18-039416.txt : 20180625 0001209191-18-039416.hdr.sgml : 20180625 20180625165157 ACCESSION NUMBER: 0001209191-18-039416 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 EFFECTIVENESS DATE: 20180625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerebral Therapeutics, Inc. CENTRAL INDEX KEY: 0001744709 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-315333 FILM NUMBER: 18917522 BUSINESS ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. CITY: AURORA STATE: CO ZIP: 840010 BUSINESS PHONE: 3035473448 MAIL ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. CITY: AURORA STATE: CO ZIP: 840010 D 1 primary_doc.xml X0708 D LIVE 0001744709 Cerebral Therapeutics, Inc. 12635 E. Montview Blvd. Aurora CO COLORADO 80010 3035473448 DELAWARE Cerebral Therapeutics, LLC None Corporation true Daniel Abrams 12635 E. Montview Blvd. Aurora CO COLORADO 80010 Executive Officer Director Chief Executive Officer Mahendra Shah 505 Hamilton Ave. Suite 207 Palo Alto CA CALIFORNIA 94301 Director Warren Lammert 109 State Street 5th Floor Boston MA MASSACHUSETTS 02109 Director Pharmaceuticals Decline to Disclose 06b false 2018-06-11 true true true false 0 7000000 2500000 4500000 false 2 0 0 0 false Cerebral Therapeutics, Inc. /s/ Daniel J. Abrams, MD Daniel J. Abrams, MD Chief Executive Officer 2018-06-20